Processa Pharmaceuticals, Inc. (PCSA)
PCSA moved a median of 0.00% 30 minutes after news, and -0.44% by the close. How PCSA actually reacts to news — the realized, point-in-time move the market made, measured across 296 labeled events over the last three years with zero look-ahead.
PCSA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 283 |
| 30-min | 0.00% | 50% | 295 |
| 60-min | -0.21% | 47% | 296 |
| to close | -0.44% | 48% | 286 |
| Middle 50% of PCSA reactions | -1.89% to +3.54% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 296 |
Half of all Processa Pharmaceuticals, Inc. news events land between -1.89% and +3.54% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when PCSA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to PCSA's baseline. Nothing else.
Recent PCSA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form PRE 14A Processa Pharmaceuticals For: Oct 09 | SEC filing · Form PRE | SEC EDGAR | -1.60% | +21.80% | |
| Form S-3 Processa Pharmaceuticals | SEC filing · Form S-3 | SEC EDGAR | -1.60% | +21.80% | |
| Form 8-K/A Processa Pharmaceuticals For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +3.21% | -4.49% | |
| Processa Pharmaceuticals to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +1.96% | +0.49% | |
| Form 10-Q Processa Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.21% | -12.35% | |
| Form 8-K Processa Pharmaceuticals For: Jul 30 | SEC filing · Form 8-K | SEC EDGAR | +0.95% | +4.29% | |
| Form 8-K Processa Pharmaceuticals For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +6.01% | +10.93% | |
| PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS | Press release | GlobeNewswire | +6.01% | +10.93% | |
| Form DEF 14A Processa Pharmaceuticals For: Jun 18 | SEC filing · Form DEF | SEC EDGAR | +0.74% | -4.15% | |
| Form 10-Q Processa Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -1.70% | -7.14% | |
| Form 10-K/A Processa Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -4.49% | |
| Form 8-K Processa Pharmaceuticals For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.49% | |
| Form 10-K Processa Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -6.91% | -25.08% | |
| Form 8-K Processa Pharmaceuticals For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | +0.44% | -8.30% | |
| Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference | Press release | GlobeNewswire | +0.91% | -4.85% | |
| Form 8-K Processa Pharmaceuticals For: Jan 06 | SEC filing · Form 8-K | SEC EDGAR | -0.57% | -1.86% | |
| Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study | Press release | GlobeNewswire | +1.47% | +5.21% | |
| Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV | Press release | ACCESS Newswire | -0.14% | +12.97% | |
| Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer | Press release | GlobeNewswire | +11.04% | +99.40% | |
| Form 8-K Processa Pharmaceuticals For: Dec 12 | SEC filing · Form 8-K | SEC EDGAR | -18.58% | -45.18% | |
| Form 10-Q Processa Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.57% | +1.93% | |
| Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025 | Press release | GlobeNewswire | +2.47% | -1.88% | |
| Form S-8 Processa Pharmaceuticals | SEC filing · Form S-8 | SEC EDGAR | +4.48% | +7.91% | |
| Form 8-K/A Processa Pharmaceuticals For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | +0.15% | +1.47% | |
| Form 8-K Processa Pharmaceuticals For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | +2.89% | +5.33% | |
| Form 8-K Processa Pharmaceuticals For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | -0.01% | +4.47% | |
| Form 8-K Processa Pharmaceuticals For: Sep 02 | SEC filing · Form 8-K | SEC EDGAR | -1.93% | +0.48% | |
| Form 8-K Processa Pharmaceuticals For: Aug 25 | SEC filing · Form 8-K | SEC EDGAR | -1.14% | +1.64% | |
| Form DEFA14A Processa Pharmaceuticals | SEC filing · Form DEFA14A | SEC EDGAR | -1.14% | +1.64% | |
| Form 8-K/A Processa Pharmaceuticals For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | +0.36% | -1.39% | |
| Form DEF 14A Processa Pharmaceuticals For: Aug 13 | SEC filing · Form DEF | SEC EDGAR | +2.73% | +3.64% | |
| Form 8-K Processa Pharmaceuticals For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +0.71% | -1.46% | |
| Form PRER14A Processa Pharmaceuticals | SEC filing · Form PRER14A | SEC EDGAR | +0.71% | -1.46% | |
| Form 10-Q Processa Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.09% | -4.70% | |
| Form 8-K Processa Pharmaceuticals For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | -3.09% | -4.70% | |
| Form PRE 14A Processa Pharmaceuticals For: Jul 31 | SEC filing · Form PRE | SEC EDGAR | +2.25% | +1.10% | |
| Form 8-K Processa Pharmaceuticals For: Jul 25 | SEC filing · Form 8-K | SEC EDGAR | +1.33% | +2.89% | |
| Form 8-K Processa Pharmaceuticals For: Jul 18 | SEC filing · Form 8-K | SEC EDGAR | -2.16% | +3.12% | |
| Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV | Press release | ACCESS Newswire | -2.54% | -3.18% | |
| Form 8-K Processa Pharmaceuticals For: Jul 15 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.51% | |
| Form 8-K Processa Pharmaceuticals For: Jun 27 | SEC filing · Form 8-K | SEC EDGAR | +3.75% | +2.88% | |
| Processa Pharmaceuticals Provides Portfolio and Business Update | Press release | GlobeNewswire | +3.75% | +2.88% | |
| Form 8-K Processa Pharmaceuticals For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +3.75% | +2.88% | |
| Form 8-K Processa Pharmaceuticals For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | -2.00% | +6.66% | |
| Form EFFECT Processa Pharmaceuticals | SEC filing · Form EFFECT | SEC EDGAR | -0.12% | -0.12% | |
| Form 8-K Processa Pharmaceuticals For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | +4.17% | -50.41% | |
| Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering | Press release | GlobeNewswire | -33.30% | -39.51% | |
| Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate | Press release | GlobeNewswire | -22.05% | -55.93% | |
| Form S-1 Processa Pharmaceuticals | SEC filing · Form S-1 | SEC EDGAR | -1.47% | -13.66% | |
| Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025 | Press release | GlobeNewswire | -1.47% | -13.66% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the PCSA section they belong to.
Where else PCSA is measured.
PCSA earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | 297 | +0.15% | 58% |
| GeoVax Labs, Inc. (GOVX) | 296 | -0.65% | 35% |
| IPSEN SA S/ADR (IPSEY) | 294 | 0.00% | 6% |
| Adicet Bio, Inc. (ACET) | 293 | -0.83% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Processa Pharmaceuticals, Inc.'s median reaction calculated?
Every labeled PCSA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 296 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 50% of PCSA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does PCSA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.